Ebola vaccine rollout begins in Democratic Republic of Congo
Scientists have begun deploying Merck's Ebola vaccine in the Democratic Republic of Congo to combat an outbreak. The effort is part of a broader health news update that also covers prostate cancer therapy and the use of Meta glasses in hospitals. The vaccine deployment aims to curb the spread of the virus.
Related stories
DRC and WHO Move Forward on Plans for Phase 3 Ebola Vaccine Trial · Infectious disease
Ongoing Ebola Outbreak in Congo Spurs Emergency Response Efforts · Infectious disease
Ivonescimab's progression-free survival benefit fades over time · Cancer research
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Scientists deploy Merck’s Ebola vaccine in DRC.” Browse more stories.